Charts

News

15 Feb, 2024
11:38
Seeking Alpha
SHELTON, CT / ACCESSWIRE / February 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that it has filed its Quarterly Report on Form 10-Q for the fiscal second quarter ...
01 Feb, 2024
SHELTON, CT / ACCESSWIRE / February 1, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, explains that the demonstration ...
31 Jan, 2024
Colds, flu and RSV aren't the only viral illnesses people have to worry about this winter. A new variant of COVID-19 is rapidly ...
29 Jan, 2024
SHELTON, CT / ACCESSWIRE / January 29, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, reported today that the healthy ...
08 Jan, 2024
NanoViricides, Inc. (NYSE American: NNVC) recently announced that it is presenting at Biotech Showcase™ 2024. Event ...
04 Jan, 2024
SHELTON, CT / ACCESSWIRE / January 4, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, announced today that it is presenting ...
29 Nov, 2023
NanoViricides CEO Dr Anil Diwan joined Steve Darling from Proactive to share exciting updates on their antiviral drug candidate, NV 387.
28 Nov, 2023
SHELTON, CT / ACCESSWIRE / November 28, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, reported today that the Single-Ascending ...
15 Nov, 2023
SHELTON, CT / ACCESSWIRE / November 15, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal first quarter ending September 30, 2023 with the Securities and Exchange ...
14 Nov, 2023
SHELTON, CT / ACCESSWIRE / November 14, 2023 / NanoViricides, Inc. (AMEX:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, reports that its broad-spectrum antiviral drug candidate, NV-387 was highly effective in an animal model that is used in drug development for MPox and Smallpox virus infections in humans.
16 Oct, 2023
SHELTON, CT / ACCESSWIRE / October 16, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Annual Report on Form 10-K for the fiscal year ending June 30, 2023 with the Securities and Exchange Commission (SEC) ...
12 Oct, 2023
SHELTON, CT / ACCESSWIRE / October 12, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), announces that the Company's President, Dr. Anil Diwan, will be presenting a talk in person at the Partnership Opportunities in Drug Delivery (PODD) ...
02 Oct, 2023
Read the latest report on NanoViricides here The CDC recently issued a warning that Respiratory Syncytial Virus (RSV), a common and ...
05 Sep, 2023
By David Bautz, PhD AMEX:NNVC In June 2023, NanoViricides, Inc. (AMEX:NNVC) announced the initiation of a Phase 1a/b safety and efficacy clinical trial of NV-CoV-2, the company’s development candidate for the treatment of COVID-19 and other coronavirus infections. The trial is evaluating two oral formulations of the compound: NV-CoV-2 oral syrup and Nv-CoV-2 oral gummies. This is an important
31 Aug, 2023
Proactive research analyst John Savin speaks to Thomas Warner after publishing a research note about the latest Covid trial from development-stage antiviral company NanoViricides (NYSE-A:NNVC).
22 Aug, 2023
Gainers Fulcrum Therapeutics (NASDAQ:FULC) stock rose 43.4% to $5.62 during Tuesday's regular session. Fulcrum Therapeutics's stock is ...
21 Aug, 2023
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, reported today that the Phase 1a/1b Human Clinical Trial of NV-CoV-2, the Company's broad-spectrum antiviral drug, is progressing successfully.
18 Jul, 2023
Read the latest report on NanoViricides here. SARS-CoV-2 is not done yet — Although it is not grabbing as many headlines, the ...
11 Jul, 2023
NanoViricides Inc(NYSE: NNVC) shares are trading higher after the company reported preclinical data from an antiviral clinical ...
Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on ...
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, reported today on the strong effectiveness of its broad-spectrum antiviral clinical drug candidate NV-387 in an animal model of lethal lung infection with RSV (Respiratory Syncytial Virus).
10 Jul, 2023
Read the latest report on NanoViricides here. NanoViricides (NYSE American: NNVC) has begun trials for its new drug candidate, ...
06 Jul, 2023
NanoViricides, Inc. (NYSE American:NNVC) (the "Company") reports that the clinical trial of its broad-spectrum antiviral drug NV-CoV-2 is progressing satisfactorily.
05 Jul, 2023
Read the latest report on NanoViricides here. NanoViricides (NYSE American: NNVC) is a drug development company working on a novel ...
08 Jun, 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Top penny stocks for June look to have legitimate catalysts that can certinly send share prices higher in the coming weeks. The post The 7 Most Promising Penny Stocks to Buy in June appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live Did Elon Musk Just Trigger a New Netscape Moment? The $1 Investment You MUST Take Advantage of Right Now The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
02 Jun, 2023
Gainers Connect Biopharma Hldgs (NASDAQ:CNTB) stock rose 44.1% to $1.6 during Friday's pre-market session. The market value of their ...
01 Jun, 2023
Gainers Trxade Health (NASDAQ:MEDS) stock moved upwards by 33.7% to $0.37 during Thursday's regular session. Trxade Health's stock is ...
31 May, 2023
NanoViricides, Inc. (NYSE Amer:NNVC) (the "Company"), announces that the Company's President, Dr. Anil Diwan, will be presenting a talk in person at the BIO International Convention in Boston on June 5th, 2023 at 3:15pm ET.
16 May, 2023
NanoViricides, Inc. (NYSE Amer:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal third quarter ending March 31, 2023 with the Securities and Exchange Commission (SEC) on Monday, May 15, 2023.
05 May, 2023
04 May, 2023
SHELTON, Conn., May 04, 2023 (GLOBE NEWSWIRE) -- (via IBN) -- NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), a clinical stage global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, announces that Anil R. Diwan, Ph.D., President of the Company will be presenting at The Inaugural EF Hutton Global Conference, which will be held on May 10-11, 2023, at the Plaza Hotel in the heart of New York City. NanoViricides is presenting on M
07 Apr, 2023
Gainers GlucoTrack (NASDAQ:GCTK) shares moved upwards by 229.8% to $1.16 during Friday's regular session. Trading volume for ...
28 Feb, 2023
UBS cut the price target for Honeywell International Inc. (NASDAQ: HON) from $193 to $185. UBS analyst Chris Snyder maintained a ...
28 Oct, 2022
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Speculative penny stocks don't look as volatile now that volatility is unavoidable. These 7 picks are worth a shot. The post 7 Speculative Penny Stocks Under $3 That Deserve Your Attention in Nov. appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
10 Aug, 2022
More than 30,000 confirmed or suspected cases of monkeypox have been reported across 93 countries in the world. While those numbers are ...
05 Aug, 2022
On Thursday, shares of NanoViricides, Inc. (NYSE: NNVC) experienced volatile short activity. After the activity, the stock price went up ...
NanoViricides, Inc. (NYSE American: NNVC) reports that it has begun drug development to combat the monkeypox virus. Specifically, the ...
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced ...
04 Aug, 2022
Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning! It's time for another dive into the biggest pre-market stock movers as we see what's affecting shares on Thursday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” Cash Holders Could Get Hit Hard THIS FRIDAY
25 May, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing ...
24 May, 2022
09:29
FinancialContent
Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its ...
23 May, 2022
Gainers Evolve Transition Infrastructure LP (NYSE: SNMP) shares rose 29.2% to $0.6699 after jumping around 14% on Friday. Forge ...
U.S. stocks traded mixed this morning, with the Dow Jones gaining around 250 points on Monday. Following the market opening Monday, ...
Gainers Genocea Biosciences, Inc. (NASDAQ: GNCA) shares rose 33.8% to $0.2795 in pre-market trading after declining around 5% on ...
07:57
FinancialContent
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 ...
22 May, 2022
Biotech stocks advanced in the week endingMay 22, defying the broader market retreat. The defensive nature of the industry and ...
20 May, 2022
08:27
FinancialContent
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA ...
19 May, 2022
The Centers for Disease Control and Prevention is now investigating 180 cases of children who suddenly developed severe hepatitis ...
16 May, 2022
NanoViricides Inc(NYSE: NNVC) hasinitiated a programto screen its library of broad-spectrum antiviral nanoviricides ...
07 Mar, 2022
Photo Credit: Photo by CDC & Klara Kulikova This post contains sponsored advertising content. This content is for ...
28 Feb, 2022
Photo credit: Marcelo Leal and Kate Hliznitsova on Unsplash This post contains sponsored advertising content. This content is for ...
Gainers Mullen Automotive, Inc. (NASDAQ: MULN) rose 45.4% to $1.00 in pre-market trading after the company reported progress on ...
15 Feb, 2022
11:52
Seeking Alpha
31 Jan, 2022
Image provided by Pixabay This post contains sponsored advertising content. This content is for informational purposes only and is ...
19 Jan, 2022
Image provided by Pixabay This post contains sponsored advertising content. This content is for informational purposes only and not ...
20 Dec, 2021
Image provided by Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house ...
09 Dec, 2021
Image provided by Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house ...
16 Nov, 2021
12:20
Seeking Alpha
03 Mar, 2021
17 Feb, 2021
11:28
Seeking Alpha
17 Nov, 2020
11:32
Seeking Alpha
04 Sep, 2020
09 Jul, 2020
30 Jun, 2020
09 Jun, 2020

Related Articles